BRYNJELSEN SEAN (President & CEO) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/14/2026ACC: 0001437749-26-001290
DirectorOfficer· President & CEO
Since Nov 2018
+253.55K
Net shares
Net buyer
$77.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
258.56K acquired · 5.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.01K
Price / share
$15.39
Trade value
$77.18K
% of position
0.2%
1/1/2026
2.89M→2.89M
Total
Net shares
−5.01K
Net value
-$77.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | F · Tax Withholding | −5.01K | $15.39 | $77.18K | 0.2% | 2.89M | 2.89M |
| Total | −5.01K | -$77.18K | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
158.05K shares
Shares
+158.05K
Strike price
15.47
Held after
3.05M
Exercisable
—
1/12/2026
Restricted Stock Units
Direct
Converts to
Common Stock
100.52K shares
Shares
+100.52K
Strike price
Held after
3.15M
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock158.05K shares | 1/12/2026 | A · Award | +158.05K | 15.47 | — | 3.05M |
| Restricted Stock Units Direct | Common Stock100.52K shares | 1/12/2026 | A · Award | +100.52K | — | 3.15M |